| Date Filed | Type | Description |
| 06/28/2023 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 08/01/2022 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 7,800 options to buy
@ $0 |
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 6,500 options to buy
@ $2.15, valued at
$14k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2017 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Sold 5,214 shares
@ $1.4942, valued at
$7.8k
|
|
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |